Gerard J. Michel
CIK: 0001235644
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- May 21, 2026BBNX
Beta Bionics, Inc.
Award(A)Direct17K shares- - Mar 2, 2026DCTH
DELCATH SYSTEMS, INC.
Purchase(P)Direct11.2K shares at avg. $8.96$100K - Feb 17, 2026DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectRestricted Stock Units
97.5K shares- - Feb 17, 2026DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectStock Option (Right to Buy)
195K shares- - Jan 13, 2026BBNX
Beta Bionics, Inc.
Award(A)Direct4K shares- - Nov 11, 2025DCTH
DELCATH SYSTEMS, INC.
Purchase(P)Direct11.5K shares at avg. $8.53$98K - Mar 26, 2025BBNX
Beta Bionics, Inc.
Award(A)Direct12.5K shares- - Feb 7, 2025DCTH
DELCATH SYSTEMS, INC.
Award(A)DirectStock Option (Right to Buy)
390K shares- - Oct 22, 2024DCTH
DELCATH SYSTEMS, INC.
Exercise(M)Direct16.7K shares at avg. $6.00$100K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 21, 2026 |  BBNX Beta Bionics, Inc. | Award(A) | 16,965 | - | $0 | Direct |
| Mar 2, 2026 |  DCTH DELCATH SYSTEMS, INC. | Purchase(P) | 11,200 | $8.96 | $100,309 | Direct |
| Feb 17, 2026 | DCTH DELCATH SYSTEMS, INC. | Award(A) Restricted Stock Units | 97,500 | - | - | Direct |
| Feb 17, 2026 | DCTH DELCATH SYSTEMS, INC. | Award(A) Stock Option (Right to Buy) | 195,000 | - | - | Direct |
| Jan 13, 2026 | BBNX Beta Bionics, Inc. | Award(A) | 3,997 | - | $0 | Direct |
| Nov 11, 2025 | DCTH DELCATH SYSTEMS, INC. | Purchase(P) | 11,500 | $8.53 | $98,049 | Direct |
| Mar 26, 2025 | BBNX Beta Bionics, Inc. | Award(A) | 12,547 | - | - | Direct |
| Feb 7, 2025 | DCTH DELCATH SYSTEMS, INC. | Award(A) Stock Option (Right to Buy) | 390,000 | - | - | Direct |
| Oct 22, 2024 | DCTH DELCATH SYSTEMS, INC. | Exercise(M) | 16,666 | $6.00 | $99,996 | Direct |
1-9 of 9 transactions
About MICHEL GERARD J
MICHEL GERARD J (SEC CIK 0001235644) files insider reports with the SEC as Director of Beta Bionics, Inc. (BBNX) and CHIEF EXECUTIVE OFFICER of DELCATH SYSTEMS, INC. (DCTH).
Signal8 holds 9 ownership filings by MICHEL GERARD J (1 Form 3, 8 Form 4), filed between Oct 23, 2024 and May 26, 2026. Those filings report 9 transactions, from Oct 22, 2024 to May 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MICHEL GERARD J's filings is in QUEENSBURY, NY.
Recent filings by MICHEL GERARD J
- May 21, 2026: Grant or award of BBNX shares (Form 4, code A).
- Mar 2, 2026: Open-market purchase of DCTH shares (Form 4, code P).
- Feb 17, 2026: Grants or awards of DCTH derivative securities (2 lines, Form 4, code A).
- Jan 13, 2026: Grant or award of BBNX shares (Form 4, code A).
- Nov 11, 2025: Open-market purchase of DCTH shares (Form 4, code P).
Other insiders filing for Beta Bionics, Inc. (BBNX)
- Mensinger Mike, Chief Product Officer
- Hopman Mark, Chief Commercial Officer
- Jones Christy, Director
- Saint Sean, President & CEO
- Russell Steven Jon, Chief Medical Officer
- Feider Stephen, Chief Financial Officer